Pritesh Shah - 06 Jul 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Commercial Officer
Signature
By: /s/ Steven Robbins, Attorney in fact for Pritesh Shah
Issuer symbol
NVCR
Transactions as of
06 Jul 2021
Net transactions value
+$21,117
Form type
4
Filing time
08 Jul 2021, 17:29:06 UTC
Previous filing
11 Jun 2021
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Restricted Share Units Award $21,117 +154 +0.2% $137.12 77,886 06 Jul 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2021 through June 30, 2021. This transaction is also exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2021.